CorVel Corporation — Form 10-Q Summary
Period clarification: The supplied filing is for the quarter ended September 30, 2021 (CorVel fiscal Q2 2022), not 2020 Q2 as indicated in the request metadata. The filing was signed November 4, 2021; interim financial statements are unaudited. Amounts below are in U.S. dollars.
Business context and reporting period
CorVel provides managed-care and medical-cost-containment services, primarily for workers’ compensation, auto insurance, and group health claims. It reports one operating segment, managed care, with revenue from patient management and network solutions. Comparisons are with the three and six months ended September 30, 2020.
Financial results and liquidity
| Metric | Quarter ended September 30 | Six months ended September 30 |
|---|---|---|
| Revenue | 2021: $157.7 million; 2020: $136.0 million; +16.0% | 2021: $310.4 million; 2020: $265.6 million; +16.8% |
| Gross profit / margin | $36.7 million / 23.2%; prior year $30.5 million / 22.4% | $73.9 million / 23.8%; prior year $57.0 million / 21.5% |
| Income before taxes | $20.0 million; prior year $14.9 million | $40.6 million; prior year $25.9 million |
| Net income | $16.1 million; prior year $11.9 million; +35.5% | $32.9 million; prior year $20.2 million; +63.2% |
| Diluted EPS | $0.88; prior year $0.65 | $1.81; prior year $1.11 |
| Operating cash flow | Six months: $35.2 million, versus $39.5 million in 2020 |
For the six months, capital expenditures were $11.6 million and treasury-stock repurchases were $39.8 million. Cash declined $8.6 million from March 31, 2021 to $131.1 million at September 30; working capital rose from $106.5 million to $109.4 million. Current assets were $272.0 million and current liabilities $162.6 million. The company reported no debt. Lease liabilities totaled $50.9 million, including $12.4 million classified within accrued liabilities and $38.5 million long term.
Changes versus the prior comparable period
- Quarterly patient management revenue rose 16.0% to $104.7 million; network solutions revenue rose 15.9% to $53.1 million. Management cited higher TPA-related revenue, a 16% increase in new claims during the quarter, and growth in enhanced bill-review services, mainly with existing customers.
- For the six months, new claims increased 18% year over year. Gross margin improved 2.3 percentage points to 23.8%; G&A as a share of revenue fell to 10.7% from 11.7%.
- Quarterly cost of revenue rose 14.7%, slower than revenue growth; management also noted 12% higher field-operations headcount. G&A increased 7.1%, reflecting marketing and IT costs.
- Operating cash flow was lower year over year, which management attributed mainly to the prior-year benefit of CARES Act payroll-tax deferrals. Investing outflows increased as capital spending, particularly on developed software, returned toward more typical levels.
Outlook, risks, and unusual items
- Management said sequential revenue had increased from the September 2020 quarter through the September 2021 quarter and expected the trend to continue in 2021, while noting uncertainty around COVID-19, vaccine distribution and effectiveness, renewed outbreaks, and economic recovery. No quantified earnings or revenue guidance was provided.
- The company stated that pandemic-related economic weakness could adversely affect future revenue, results, financial condition, and cash flows, notwithstanding the recovery reflected in the reported period. Most employees continued to work from home; management also cited possible lasting changes to office-space needs.
- Management considered cash and anticipated internally generated funds adequate for obligations and planned activity for at least 12 months, but said repurchases could be reduced or suspended if earnings or cash flows weaken. It deferred $10.4 million of payroll taxes under the CARES Act, with repayment scheduled in halves by the ends of calendar 2021 and 2022.
- CorVel repurchased 284,348 shares for $39.8 million during the six months and 165,455 shares for $25.6 million in the quarter. After quarter-end, it repurchased another 49,663 shares for $8.7 million. The board expanded the cumulative authorization to 38 million shares in May 2021.
- COVID-19-related lease reassessments reduced certain lease terms and related right-of-use assets and liabilities, with an immaterial income-statement impact. Approximately $6.7 million of additional operating lease commitments had not yet commenced.
- Ordinary-course litigation was disclosed; management did not expect it to result in material payments. The filing also highlights competition, claim volumes and customer outsourcing decisions, labor and benefit costs, regulation, cybersecurity, and software development as risks. No off-balance-sheet arrangements were reported.
Important facts for investors to verify
- Confirm the period: this is the September 30, 2021 Form 10-Q, not a 2020 Q2 filing.
- Assess whether revenue and new-claim growth can persist as pandemic-related comparisons normalize, and monitor customer demand and claim volumes.
- Track operating cash conversion, capital spending, payroll-tax repayments, and the pace of share repurchases against cash generation.
- Review the filing’s risk-factor disclosures on COVID-19, competition, labor costs, cybersecurity, regulatory exposure, and potential litigation.
- Distinguish reported lease obligations from debt: the company reported no debt but had $50.9 million of lease liabilities.